Highlights Zhongsheng Group Holdings Limited

Equities

881 KYG9894K1085

Delayed Hong Kong S.E. Other stock markets 12:00:59 28/06/2024 pm IST			5-day change	1st Jan Change
11.34 ^HKD	+2.16%		-6.59%	-39.29%

25/06	Zhongsheng Group Slashes Conversion Price of 2025 Bonds	MT
24/06	Zhongsheng Group Holdings Limited Commences an Equity Buyback Plan for 238,566,836 shares, representing 10% of its issued share capital, under the authorization approved on June 21, 2024.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhongsheng Group Slashes Conversion Price of 2025 Bonds	25/06	MT
Zhongsheng Group Holdings Limited Commences an Equity Buyback Plan for 238,566,836 shares, representing 10% of its issued share capital, under the authorization approved on June 21, 2024.	24/06	CI
Zhongsheng Group Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023, to Be Distributed on 12 July 2024	21/06	CI
Zhongsheng Group Holdings Limited's Equity Buyback announced on July 12, 2023, has expired.	21/06	CI
China and HK stocks close down despite upbeat service activity data	05/06	RE
China Grants Approval to Zhongsheng Pharma's Eye Drops	28/05	MT
Zhongsheng Group Plans to Issue Up to 5 Billion Yuan Panda Bonds	21/05	MT
Renaissance Asia Silk Road Raises Over HK$22 Million from Share Issue	22/04	MT
Beijing, Washington Inflation Reports Blunt Asian Stock Markets	11/04	MT
Zhongsheng Group's 2023 Profit Falls on Lower Revenue; New CFO Named	27/03	MT
Zhongsheng Group Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 July 2024	27/03	CI
Zhongsheng Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
Tech Sector, Earnings, Wall Street Cues Churn Asian Stock Marlets	26/03	MT
Zhongsheng Pharma's Unit Gets Nod to Market Mirabegron	18/01	MT
Henan Jinyuan Hydrogenated Chemicals Launches Up to HK$358 Million Hong Kong IPO Following Spin-Off from Parent	12/12	MT
Zhongsheng Pharma Chairman Plans Boosting Stake	08/12	MT
Zhongsheng Pharmaceutical Gets Drug Registration Certificate for Carbocysteine Oral Solution	18/23/18	MT
Zhongsheng Group's Profit Drops 12.8% in H1	24/23/24	MT
Zhongsheng Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Bargain Hunting Lifts Asian Stock Markets	22/23/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zhongsheng Group Holdings Limited

Equities

881

KYG9894K1085

Highlights

Filters